InsiderDB

Follow the company. Check the evidence.

Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.

Clear
  1. VRTXLobbying report·Lobbying disclosures

    VRTX: second_quarter 2026 lobbying report

    H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language Monitor issues related to 340b;

    Public: Jul 20, 2026, 2:32 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. VRTXLobbying report·Lobbying disclosures

    VRTX: second_quarter 2026 lobbying report

    Access to innovative non-opioid medicines. Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.

    Public: Jul 19, 2026, 9:54 AM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. VRTXLobbying report·Lobbying disclosures

    VRTX: second_quarter 2026 lobbying report

    General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about non-opioid pain therapies.H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about precision medicine. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about the importance of access to non-opioid pain therapies for Medicare beneficiaries. H.R.1227/

    Public: Jul 17, 2026, 10:36 AM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  4. VRTXLobbying report·Lobbying disclosures

    VRTX: second_quarter 2026 lobbying report

    Federal budget issues Lobbying related to pharmaceutical policy Lobbying related to pharmaceutical and Medicare/Medicaid policy

    Public: Jul 16, 2026, 4:48 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  5. VRTXLobbying report·Lobbying disclosures

    VRTX: second_quarter 2026 lobbying report

    Issues related to HR 1227, Alternatives to Pain Act

    Public: Jul 16, 2026, 12:25 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  6. VRTXLobbying report·Lobbying disclosures

    VRTX: second_quarter 2026 lobbying report

    Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, H.R. 6423/S. 864 - HELP Copays Act; Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; General education about kidney disease, including APOL-1 and H.R. 1518 - New Era of Preventing End-Stage Kidney Disease; Cystic Fibrosis; Sickle cell disease; Innovations in Type 1 diabetes treatments. Unmet medical need in acute pain; H.R. 1227/S. 475 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-32

    Public: Jul 16, 2026, 11:05 AM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  7. VRTXCompany announcement·SEC EDGAR

    VRTX: Material agreement · Company disclosure · Other company developments

    Filed 8-K for an event or period dated 2026-07-06. Material agreement; Company disclosure; Other company developments.

    Public: Jul 6, 2026, 9:55 PM EDTEvent / period: Jul 6, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  8. VRTXCompany announcement·SEC EDGAR

    VRTX: Leadership change

    Filed 8-K for an event or period dated 2026-05-13. Leadership change.

    Public: May 13, 2026, 4:03 PM EDTEvent / period: May 13, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.

Source coverage

Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.

SEC EDGAR
Current across tracked companies505 of 505 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:26 PM EST
USAspending
Collection in progress72 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:27 PM EST
SAM.gov
Awaiting company connections
Lobbying disclosures
Not yet scanned0 of 548 companies scanned in the past 12 hours
Congress.gov
Current across tracked companies5 of 5 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:19 PM EST
Federal Register
Collection in progress296 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:27 PM EST
Regulations.gov
Partial coverage — some requests unavailable32 of 53 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:19 PM EST
FEC campaign finance
Stale — refresh overdue0 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 11, 2026, 1:28 PM EST